304 filings
Page 9 of 16
6-K
5q6j4rj3w72djszvx1r
9 Aug 16
GW Pharmaceuticals plc Reports Third Quarter 2016 Financial Results and Operational Progress
12:00am
6-K
ldenwtqt12fz9 09zwh
18 Jul 16
Current report (foreign)
12:00am
424B5
vewur 8vpbpi59jkwzso
14 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
fpccc28
14 Jul 16
Current report (foreign)
12:00am
FWP
nvx4zzscst6kr3q
13 Jul 16
Free writing prospectus
12:00am
424B5
cfv2a0
12 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
zmqcep rrkr
12 Jul 16
Current report (foreign)
12:00am
6-K
auduuwu2c sox0
27 Jun 16
GW Pharmaceuticals Announces Positive Phase 3 Pivotal Trial Results for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome
12:00am
6-K
xzeoa6x1sljrf m81vt
21 Jun 16
Current report (foreign)
12:00am
CT ORDER
21t 437ocz62vfq5s2
16 Jun 16
Confidential treatment order
12:00am
6-K
e7hknx4 duiodjzibqsw
13 May 16
Current report (foreign)
12:00am
6-K
5hqzt0c 4p
5 May 16
GW Pharmaceuticals plc Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
12:00am
6-K
31qqe7d55
25 Apr 16
GW Pharmaceuticals Receives Orphan Drug Designation from FDA for Cannabidiol for the Treatment of Tuberous Sclerosis Complex
12:00am
6-K
kmrk4zcv
11 Apr 16
Current report (foreign)
12:00am
6-K
cl6s2q4f78t df56724
1 Apr 16
Current report (foreign)
12:00am
6-K
bzesir3g
14 Mar 16
Current report (foreign)
12:00am
6-K
cq154g1h
19 Feb 16
Current report (foreign)
12:00am
SC 13G/A
nmyh4
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
vddey84d8 pad
16 Feb 16
GW Pharmaceuticals PLC
12:00am
SC 13G/A
6zlr 8a6obv7iybk8cy4
12 Feb 16
GW Pharmaceuticals PLC
12:00am